FDA Approves Lenvatinib) for Treatment of mRCC

U.S. Food and Drug Administration (FDA) approved Lenvima (lenvatinib, in combination with everolimus for the treatment of patients with advanced renal cell carcinoma...05/16/2016
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news